Filing Details
- Accession Number:
- 0001562180-24-006946
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 20:25:15
- Reporting Period:
- 2024-09-20
- Accepted Time:
- 2024-09-24 20:25:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191702 | R John Moore | C/O Edgewise Therapeutics, Inc. 1715 38Th Street Boulder CO 80301 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-20 | 50,000 | $0.71 | 53,252 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-20 | 50,000 | $28.37 | 3,252 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-23 | 20,922 | $0.71 | 24,174 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-23 | 20,922 | $27.63 | 3,252 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-20 | 50,000 | $0.00 | 50,000 | $0.71 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-23 | 20,922 | $0.00 | 20,922 | $0.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 62,558 | 2030-09-01 | No | 4 | M | Direct | |
| 41,636 | 2030-09-01 | No | 4 | M | Direct |
Footnotes
- 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.
Billionaire Hedge Funds
